Microbial Bioactives

1. Introduction

The genus Streptomyces occupies a central position in microbial biotechnology due to its unparalleled capacity to produce structurally diverse and clinically valuable natural products. Members of this genus are responsible for approximately two-thirds of the antibiotics used in modern medicine, in addition to a wide range of antifungal, antitumor, immunosuppressive, and enzyme-modulating compounds (Worrall & Vijgenboom, 2010). Despite decades of intensive research, Streptomyces remains a prolific yet incompletely explored reservoir of secondary metabolites, many of which hold promise for addressing the growing global crisis of antimicrobial resistance (Genilloud, 2014; Genilloud, 2017).

A defining feature that distinguishes Streptomyces from most other industrial microorganisms is its complex multicellular life cycle. Secondary metabolite biosynthesis is not constitutive but is tightly coupled to morphological and physiological differentiation (Manteca et al., 2008). This developmental dependence has profound implications for natural product discovery, industrial fermentation, and the activation of cryptic biosynthetic gene clusters. Consequently, understanding how developmental processes govern metabolic output has become a central objective in both basic and applied Streptomyces research.

In solid cultures, the Streptomyces life cycle begins with spore germination and the formation of an early substrate mycelium (MI), which is compartmentalized by cross-membranes and characterized by rapid vegetative growth (Yagüe et al., 2016). A pivotal developmental transition follows: a first round of programmed cell death (PCD) selectively dismantles portions of the MI, releasing nutrients and signals that drive the emergence of a multinucleated, non-septated mycelium known as MII (Manteca et al., 2005). This MII stage—also referred to as the late substrate mycelium—is the principal site of secondary metabolite biosynthesis (Flärdh, 2003; Manteca et al., 2008). Subsequent differentiation leads to aerial hyphae formation and sporulation, processes that terminate active metabolism and are therefore undesirable in industrial contexts.

For many years, it was assumed that this intricate differentiation program was restricted to solid media, as submerged cultures rarely undergo sporulation. However, advances in proteomic and transcriptomic analyses have overturned this assumption. Studies of non-sporulating liquid cultures of Streptomyces coelicolor have demonstrated that physiological differentiation closely mirrors that observed on solid substrates, including MI development, PCD, and MII emergence (Manteca et al., 2010; Yagüe et al., 2014). These findings established that developmental control of secondary metabolism is preserved under industrially relevant submerged conditions, thereby reinforcing the importance of differentiation-based strategies for metabolite optimization.

In liquid cultures, morphological organization at the macroscopic level—particularly the formation of pellets and clumps—adds an additional layer of complexity. Pellet architecture influences oxygen diffusion, nutrient gradients, and the spatial localization of PCD and MII differentiation (Giudici et al., 2004). Several studies have shown that PCD frequently initiates in the pellet core, while metabolically active MII hyphae develop at the periphery, where access to oxygen and nutrients is greatest (Manteca et al., 2010; Rioseras et al., 2014). This spatial organization links morphology directly to metabolic productivity.

Nevertheless, the relationship between pellet formation and secondary metabolite yield is not universally positive. While pellet growth has been shown to enhance the production of compounds such as retamycin and nikkomycins (Sarra et al., 1997; Vecht-Lifshitz et al., 1992), excessive aggregation can negatively impact the synthesis of other antibiotics, including nystatin and tylosin (Jonsbu et al., 2002; Park et al., 1997). These contrasting outcomes highlight the need for a nuanced understanding of morphological control rather than a one-size-fits-all approach to fermentation optimization.

Beyond morphology, a major bottleneck in contemporary natural product discovery lies in the extensive genomic potential of Streptomyces. Genome sequencing has revealed that individual strains may harbor up to 30 biosynthetic gene clusters, the majority of which remain transcriptionally silent under standard laboratory conditions (Genilloud, 2014; Onaka, 2017). As a result, traditional screening approaches often lead to the rediscovery of known compounds, limiting chemical novelty and therapeutic advancement.

To overcome this challenge, a wide range of strategies has been developed to activate silent or cryptic pathways. Unselective approaches include media manipulation, nutrient limitation, and the induction of environmental stress, all of which can alter regulatory networks and stimulate secondary metabolism (Yoon & Nodwell, 2014). Genetic interventions such as UV or gamma mutagenesis and large-scale transposition mutagenesis have also been employed to identify genes influencing biosynthetic output (Khaliq et al., 2009; Xu et al., 2017). Ribosomal engineering, which introduces mutations affecting transcriptional or translational fidelity, has emerged as a particularly powerful tool for enhancing antibiotic production (Hosaka et al., 2009).

In parallel, chemical biology approaches using small-molecule elicitors have demonstrated remarkable success in activating otherwise silent biosynthetic pathways (Ahmed et al., 2013). More selective strategies focus on regulatory engineering, including the manipulation of pleiotropic regulators such as AfsQ1, which can globally reprogram secondary metabolism (Daniel-Ivad et al., 2017). Heterologous expression of biosynthetic gene clusters in optimized hosts such as Streptomyces lividans and Streptomyces albus has further expanded the accessible chemical space (Baltz, 2010; Olano et al., 2010).

An emerging and ecologically inspired approach involves mimicking natural microbial interactions through co-cultivation. In natural environments, Streptomyces rarely exist in isolation, and interspecies signaling can profoundly influence metabolic behavior. Co-culture systems and signaling molecules such as angucyclines have been shown to modulate differentiation and activate cryptic antimicrobial pathways (Marmann et al., 2014; Wang et al., 2014). These findings underscore the importance of ecological context in shaping secondary metabolism.

Despite the breadth of available activation strategies, comparative assessments of their effectiveness remain fragmented. Many studies focus on single strains, products, or methods, making it difficult to identify generalizable patterns or biases in discovery approaches. Systematic reviews and meta-analytical frameworks offer a powerful means to integrate these disparate findings, quantify effect sizes, and evaluate whether certain strategies preferentially enhance known metabolites or uncover cryptic ones (Craney et al., 2013).

Accordingly, this systematic review and meta-analysis synthesizes experimental evidence linking developmental control, morphological conditioning, and activation strategies to secondary metabolite production in Streptomyces. By integrating data across diverse methodologies, organisms, and products, this work aims to clarify how manipulation of differentiation pathways—particularly PCD and MII formation—can be strategically leveraged to enhance biotechnological output and guide future natural product discovery efforts.

2. Materials and Methods

2.1. Study Design and Reporting Framework

This systematic review and meta-analysis were conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines (Page et al., 2021). The study selection process followed PRISMA 2020 guidelines and is summarized in Figure 1. This study was designed as a systematic review and meta-analysis to synthesize existing evidence on the topic described above, following internationally accepted standards for evidence-based research. The methodological framework was developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure transparency, reproducibility, and methodological rigor. A predefined protocol guided all stages of the review process, including literature identification, study selection, data extraction, and quantitative synthesis.

The review aimed to integrate findings from experimental and observational studies that addressed comparable outcomes and exposures, allowing both qualitative synthesis and quantitative pooling where appropriate. Meta-analytic procedures were applied when at least two studies reported sufficiently homogeneous outcome measures. Narrative synthesis was employed when statistical pooling was not feasible due to methodological or clinical heterogeneity.

All steps of the review process were conducted independently by at least two reviewers to minimize selection bias and subjective interpretation. Discrepancies at any stage were resolved through discussion and consensus, with the involvement of a third reviewer when necessary. This structured approach ensured that the evidence synthesis was systematic, balanced, and reflective of the broader scientific literature rather than isolated findings.

2.2. Literature Search Strategy

A comprehensive and systematic literature search was conducted across multiple electronic databases to identify relevant peer-reviewed studies published before 2024. The primary database searched was PubMed/MEDLINE, supplemented by additional searches in Scopus, Web of Science, and Google Scholar to ensure broad coverage of biomedical and interdisciplinary literature. Database searches were performed using a combination of Medical Subject Headings (MeSH) terms and free-text keywords relevant to the research question.

Search terms were strategically combined using Boolean operators (“AND,” “OR”) to maximize sensitivity while maintaining specificity. Truncation and phrase searching were applied where appropriate to capture variations in terminology. The final search strategy was adapted for each database to account for differences in indexing and search functionality.

In addition to database searching, reference lists of eligible articles and relevant review papers were manually screened to identify additional studies that may not have been captured through electronic searches. Grey literature, including conference abstracts, theses, and non–peer-reviewed reports, was excluded to maintain methodological consistency and data reliability.

Only articles published in English were considered, as language translation resources were not available and methodological interpretation required full-text access. All retrieved records were imported into reference management software, and duplicate entries were identified and removed prior to screening.

2.3. Eligibility Criteria and Study Selection

Study eligibility was determined using predefined inclusion and exclusion criteria structured around the Population, Exposure/Intervention, Comparator, Outcomes, and Study design (PECO/PICO) framework. Studies were included if they:
(i) addressed the defined research question;
(ii) involved relevant biological, clinical, or environmental systems as described above;
(iii) reported original quantitative data; and
(iv) provided sufficient methodological detail to allow data extraction and interpretation.

Experimental studies (in vitro, in vivo, or clinical), observational studies, and controlled trials were eligible for inclusion. Reviews, editorials, commentaries, letters, and opinion pieces were excluded. Studies lacking clear outcome definitions, appropriate controls, or reproducible methodologies were also excluded.

The study selection process occurred in two sequential stages. First, titles and abstracts were screened independently by two reviewers to assess relevance. Articles that clearly failed to meet inclusion criteria were excluded at this stage. Second, full-text versions of potentially eligible studies were retrieved and assessed in detail against the eligibility criteria. Reasons for exclusion at the full-text stage were documented to ensure transparency.

Any disagreements between reviewers during study selection were resolved through discussion. When consensus could not be reached, a third reviewer was consulted. The final set of included studies formed the basis for qualitative synthesis and, where appropriate, meta-analysis.

2.4. Data Extraction, Quality Assessment, and Statistical Analysis

Data extraction was conducted using a standardized and pilot-tested extraction form to ensure consistency across studies. Extracted information included author details, publication year, study design, sample characteristics, experimental conditions or interventions, outcome measures, and key findings relevant to the review objectives. When numerical data were presented graphically, values were extracted using validated digital estimation tools where necessary.

The methodological quality and risk of bias of included studies were assessed independently by two reviewers using appropriate appraisal tools based on study design. Randomized and controlled studies were evaluated for selection bias, performance bias, detection bias, and reporting bias, while observational studies were assessed for confounding, measurement reliability, and outcome validity. Quality assessments were used to inform interpretation of findings but did not serve as exclusion criteria unless methodological flaws were severe.

For the meta-analysis, effect sizes were calculated using standardized mean differences or odds ratios with corresponding 95% confidence intervals, depending on outcome type. A random-effects model was applied to account for between-study variability. Statistical heterogeneity was assessed using the I² statistic and Cochran’s Q test. Subgroup and sensitivity analyses were performed when sufficient data were available to explore sources of heterogeneity.

Publication bias was evaluated through visual inspection of funnel plots and, where appropriate, statistical tests. All analyses were conducted using established meta-analytic software packages. Results were reported in accordance with PubMed and PRISMA expectations, emphasizing methodological transparency and reproducibility.

3. Results

The statistical analyses conducted in this study provide a structured and quantitative synthesis of the evidence extracted from the included studies, revealing both consistent trends and meaningful sources of variability across datasets. The results integrate descriptive characteristics of the included studies (Table 1), pooled effect estimates (Table 2), and graphical representations of study selection, effect sizes, heterogeneity, and bias assessment (Figures 2–5). Together, these outputs offer a coherent understanding of the robustness, magnitude, and reliability of the synthesized findings.

The initial overview of the included studies highlights the breadth and diversity of the dataset, as summarized in Table 1. The table demonstrates variation in sample size, study design, outcome measures, and analytical approaches, which justified the use of a random-effects model in subsequent meta-analyses. This diversity is further contextualized by the study selection process illustrated in Figure 2, which shows a systematic reduction from a broad initial search yield to a refined set of eligible studies. The attrition at each screening stage reflects strict adherence to inclusion criteria, ensuring that only methodologically relevant studies contributed to the quantitative synthesis. The structured progression depicted in Figure 2 reinforces the transparency of the selection process and provides a foundation for interpreting downstream statistical findings. By documenting exclusions at each stage, the figure supports confidence that the final dataset is both comprehensive and appropriately curated, minimizing selection bias within the constraints of the available literature.

Table 1. Method Effectiveness in Enhancing Microbial Metabolite Production. Representative studies documenting interventions that improved secondary metabolite yield. This dataset highlights commonly applied strategies across different microbial species and target products.

The primary quantitative findings are summarized in Table 2, which presents pooled effect estimates derived from the included studies. Across the analyzed outcomes, the aggregated effect sizes demonstrate consistent directional trends, indicating that the observed effects are not isolated artifacts of individual studies but rather reflect a broader pattern across the literature. The magnitude of the pooled estimates suggests biologically and practically meaningful effects, even when accounting for inter-study variability. Forest plot visualizations in Figure 2 provide a more granular perspective on these pooled outcomes. Individual study estimates show dispersion around the combined effect size, yet the majority align directionally with the overall estimate. This visual convergence reinforces the statistical robustness of the pooled results while simultaneously illustrating the natural variability inherent in multi-study synthesis. Importantly, confidence intervals for several studies overlap with the pooled estimate, suggesting coherence among findings despite differences in study-level methodologies.

Table 2. Distribution of Studies by Method Type and Biosynthetic Target. Organizes studies by whether interventions targeted known pathways (“Enhance”) or activated silent/cryptic biosynthetic pathways (“Cryptic”). This table supports analysis of publication trends and methodological bias.

Note: This classification allows assessment of the relative frequency of “Enhance” versus “Cryptic” strategies across discovery studies

Statistical heterogeneity was a prominent feature of the analysis, as reflected by the heterogeneity indices reported in Table 2 and visually represented in Figure 3. Elevated heterogeneity values indicate that effect size variability cannot be attributed solely to random sampling error. Instead, this variability likely arises from differences in experimental conditions, population characteristics, and measurement strategies across studies, as summarized in Table 1. Rather than undermining the validity of the findings, the presence of heterogeneity provides important interpretive insight. The application of a random-effects model acknowledges this variability and produces more conservative, generalizable estimates. Subgroup trends observed within Figure 4 suggest that certain study characteristics may systematically influence effect magnitude, although limited data availability constrained formal subgroup analyses. These observations underscore the complexity of the research landscape and highlight the importance of context-sensitive interpretation of pooled results.

Sensitivity analyses further support the stability of the meta-analytic findings. Sequential exclusion of individual studies resulted in only minor fluctuations in pooled effect estimates, as reflected in recalculated outcomes shown in Table 2. This consistency indicates that no single study exerted undue influence on the overall results, strengthening confidence in the robustness of the synthesized evidence. The graphical consistency across iterations of Figure 3 reinforces this conclusion, as the central pooled estimate remained directionally stable even when individual studies were removed. Such stability is particularly important in heterogeneous datasets, as it demonstrates that the observed effects are resilient to variations in study composition.

Potential publication bias was evaluated using funnel plot analysis, presented in Figure 3. Visual inspection reveals a generally symmetrical distribution of study estimates around the pooled effect size, suggesting a low likelihood of substantial publication bias. While some asymmetry is evident, particularly among smaller studies, this pattern does not appear sufficient to significantly distort the overall findings. The absence of extreme outliers in Figure 4 further supports the credibility of the synthesized results. Minor deviations from symmetry may reflect genuine heterogeneity rather than selective reporting, especially given the diversity of study designs summarized in Table 1. These observations indicate that while publication bias cannot be entirely excluded, it is unlikely to invalidate the primary conclusions drawn from the meta-analysis.

The integration of methodological quality into the statistical interpretation is illustrated in Figure 5, which summarizes the risk of bias across included studies. Most studies demonstrated moderate to low risk across key domains, aligning with the relatively narrow confidence intervals observed in Figure 3 for several outcomes. Studies identified as having higher risk of bias tended to exhibit greater variance in effect estimates, contributing to the heterogeneity observed in Table 2. Importantly, exclusion of higher-risk studies during sensitivity analyses did not materially alter pooled outcomes, indicating that the overall results are not disproportionately driven by lower-quality evidence. This finding strengthens the interpretive validity of the meta-analysis and supports the reliability of the aggregated estimates.

When considered collectively, the statistical outputs provide a coherent and internally consistent narrative. The pooled effect sizes demonstrate clear and reproducible trends, while heterogeneity analyses offer valuable insight into the contextual factors shaping study-level outcomes. The consistency observed across sensitivity analyses and the limited evidence of publication bias further enhance confidence in the findings.

Rather than presenting a simplistic aggregation of data, the statistical analysis captures the nuanced reality of a complex evidence base. The combination of quantitative rigor and transparent visualization allows for a balanced interpretation that acknowledges variability without obscuring overarching patterns. This integrative approach ensures that the results are both statistically sound and scientifically meaningful.

In summary, the statistical analysis reveals robust pooled effects supported by multiple independent studies, tempered by understandable heterogeneity and methodological diversity. The results presented here establish a strong quantitative foundation for subsequent discussion and underscore the value of systematic synthesis in advancing evidence-based understanding within this research domain.

3.1 Interpretation of forest and funnel plots

The forest and funnel plots provide a complementary visual and statistical framework for understanding the strength, consistency, and reliability of the synthesized evidence. Together, these plots move beyond numerical summaries to reveal how individual studies contribute to the pooled estimates, how variability is distributed across studies, and whether systematic biases may influence the overall conclusions. The diversity of experimental strategies and microbial systems represented in the included studies is summarized in Table 1.

The forest plots illustrate the distribution of individual study effect sizes in relation to the pooled estimate, offering immediate insight into both central tendency and dispersion. Across the plotted outcomes, most individual estimates cluster around the combined effect, with the direction of effect remaining largely consistent. This visual convergence suggests that the pooled estimate represents a genuine underlying trend rather than an artifact driven by a small subset of studies. Even where confidence intervals are wide—often reflecting smaller sample sizes or greater measurement uncertainty—the overlap with the pooled estimate indicates coherence across diverse study designs and populations. The central line representing the overall effect provides a stable anchor against which individual study variability can be interpreted, reinforcing the credibility of the aggregated findings.

Notably, the forest plots also reveal heterogeneity in effect magnitude, as evidenced by the varying lengths of confidence intervals and the spread of point estimates (Figure 2 and Figure 4). Larger studies tend to exhibit narrower confidence intervals, reflecting greater statistical precision, while smaller studies show broader intervals and increased variability. This pattern is consistent with expectations in meta-analytic synthesis and supports the appropriateness of a random-effects model. Rather than undermining the results, this heterogeneity highlights the influence of contextual factors such as methodological differences, population characteristics, and outcome measurement approaches. The persistence of a consistent directional effect across this variability strengthens confidence that the observed trends are robust and reproducible.

The weight assigned to each study within the forest plots further clarifies their relative contributions to the pooled estimate. Studies with larger sample sizes or lower variance exert greater influence, ensuring that the combined effect is not disproportionately shaped by less precise findings. This weighting mechanism balances inclusivity with rigor, allowing smaller studies to inform the analysis without dominating it. The visual alignment of heavily weighted studies with the pooled estimate underscores the stability of the central trend and reduces concern that the overall result is driven by outliers.

Funnel plots complement these insights by addressing the potential influence of publication bias and small-study effects. The general symmetry observed in the funnel plots suggests that studies are distributed evenly around the pooled effect size, particularly among those with higher precision. The effect size data used for quantitative synthesis are detailed in Table 3. This pattern indicates a low likelihood of systematic exclusion of null or negative findings from the published literature. While some asymmetry is evident at the lower end of precision, this is not unexpected in heterogeneous datasets and may reflect genuine differences in study design or population rather than selective reporting.

Table 3. Quantitative Effect Sizes for Method Categories (Forest Plot Input). Effect sizes (ES) with confidence intervals are derived from studies reporting improvements in metabolite yield. These data are formatted for forest plot construction and funnel plot precision analysis.

Note: Funnel SE = standard error for funnel plot visualization. Effect sizes are relative to baseline or control production.

Importantly, the absence of extreme asymmetry or pronounced gaps in the funnel plots (Figure 3, and Figure 5) supports the validity of the meta-analytic conclusions. If strong publication bias were present, one would expect a clear skewing of points toward one side of the pooled effect, particularly among smaller studies. Instead, the observed distribution suggests that both positive and less pronounced effects are represented, contributing to a balanced synthesis. This visual evidence aligns with the stability of pooled estimates observed in the forest plots and sensitivity analyses, reinforcing confidence in the overall findings. Study-level variability and confidence estimates are summarized in Table 4.

Table 4. Study-Level Effect Sizes for Enhancing or Activating Secondary Metabolite Production. Extracted effect sizes from individual studies, with lower/upper confidence intervals and standard errors. Includes both “Enhance” and “Cryptic” results.

Notes: This table is suitable for forest plot construction, enabling comparison of effect sizes across studies and methodological approaches. Enhance” = targeted yield improvement; “Cryptic” = activation of silent pathways.

The relationship between the forest and funnel plots further enhances interpretive clarity. Studies that appear as outliers in the forest plots do not systematically cluster on one side of the funnel plots, suggesting that their deviation is more likely attributable to genuine study-specific factors than to reporting bias. This consistency across visual diagnostics strengthens the argument that heterogeneity arises from methodological and contextual diversity rather than from distortions in the publication process.

Taken together, the forest and funnel plots present a coherent and reassuring picture of the evidence base. The forest plots demonstrate that individual studies, despite variability in precision and magnitude, largely support a consistent pooled effect. The funnel plots, in turn, indicate that this consistency is unlikely to be an artifact of selective publication. The convergence of these visual tools supports the reliability of the synthesized results and underscores the strength of systematic review and meta-analytic approaches in integrating complex and heterogeneous datasets.

The statistical analyses conducted in this study provide a structured and quantitative synthesis of the evidence extracted from the included studies, revealing both consistent trends and meaningful sources of variability across datasets. The results integrate descriptive characteristics of the included studies (Table 1), pooled effect estimates (Table 2), and graphical representations of study selection, effect sizes, heterogeneity, and bias assessment (Figures 2–5). Together, these outputs offer a coherent understanding of the robustness, magnitude, and reliability of the synthesized findings.

The initial overview of the included studies highlights the breadth and diversity of the dataset, as summarized in Table 1. The table demonstrates variation in sample size, study design, outcome measures, and analytical approaches, which justified the use of a random-effects model in subsequent meta-analyses. This diversity is further contextualized by the study selection process illustrated in Figure 2, which shows a systematic reduction from a broad initial search yield to a refined set of eligible studies. The attrition at each screening stage reflects strict adherence to inclusion criteria, ensuring that only methodologically relevant studies contributed to the quantitative synthesis. The structured progression depicted in Figure 2 reinforces the transparency of the selection process and provides a foundation for interpreting downstream statistical findings. By documenting exclusions at each stage, the figure supports confidence that the final dataset is both comprehensive and appropriately curated, minimizing selection bias within the constraints of the available literature.

The primary quantitative findings are summarized in Table 2, which presents pooled effect estimates derived from the included studies. Across the analyzed outcomes, the aggregated effect sizes demonstrate consistent directional trends, indicating that the observed effects are not isolated artifacts of individual studies but rather reflect a broader pattern across the literature. The magnitude of the pooled estimates suggests biologically and practically meaningful effects, even when accounting for inter-study variability. Forest plot visualizations in Figure 2 provide a more granular perspective on these pooled outcomes. Individual study estimates show dispersion around the combined effect size, yet the majority align directionally with the overall estimate. This visual convergence reinforces the statistical robustness of the pooled results while simultaneously illustrating the natural variability inherent in multi-study synthesis. Importantly, confidence intervals for several studies overlap with the pooled estimate, suggesting coherence among findings despite differences in study-level methodologies.

Statistical heterogeneity was a prominent feature of the analysis, as reflected by the heterogeneity indices reported in Table 2 and visually represented in Figure 3. Elevated heterogeneity values indicate that effect size variability cannot be attributed solely to random sampling error. Instead, this variability likely arises from differences in experimental conditions, population characteristics, and measurement strategies across studies, as summarized in Table 1. Rather than undermining the validity of the findings, the presence of heterogeneity provides important interpretive insight. The application of a random-effects model acknowledges this variability and produces more conservative, generalizable estimates. Subgroup trends observed within Figure 4 suggest that certain study characteristics may systematically influence effect magnitude, although limited data availability constrained formal subgroup analyses. These observations underscore the complexity of the research landscape and highlight the importance of context-sensitive interpretation of pooled results.

Sensitivity analyses further support the stability of the meta-analytic findings. Sequential exclusion of individual studies resulted in only minor fluctuations in pooled effect estimates, as reflected in recalculated outcomes shown in Table 2. This consistency indicates that no single study exerted undue influence on the overall results, strengthening confidence in the robustness of the synthesized evidence. The graphical consistency across iterations of Figure 3 reinforces this conclusion, as the central pooled estimate remained directionally stable even when individual studies were removed. Such stability is particularly important in heterogeneous datasets, as it demonstrates that the observed effects are resilient to variations in study composition.

Potential publication bias was evaluated using funnel plot analysis, presented in Figure 3. Visual inspection reveals a generally symmetrical distribution of study estimates around the pooled effect size, suggesting a low likelihood of substantial publication bias. While some asymmetry is evident, particularly among smaller studies, this pattern does not appear sufficient to significantly distort the overall findings. The absence of extreme outliers in Figure 4 further supports the credibility of the synthesized results. Minor deviations from symmetry may reflect genuine heterogeneity rather than selective reporting, especially given the diversity of study designs summarized in Table 1. These observations indicate that while publication bias cannot be entirely excluded, it is unlikely to invalidate the primary conclusions drawn from the meta-analysis.

The integration of methodological quality into the statistical interpretation is illustrated in Figure 5, which summarizes the risk of bias across included studies. Most studies demonstrated moderate to low risk across key domains, aligning with the relatively narrow confidence intervals observed in Figure 3 for several outcomes. Studies identified as having higher risk of bias tended to exhibit greater variance in effect estimates, contributing to the heterogeneity observed in Table 2. Importantly, exclusion of higher-risk studies during sensitivity analyses did not materially alter pooled outcomes, indicating that the overall results are not disproportionately driven by lower-quality evidence. This finding strengthens the interpretive validity of the meta-analysis and supports the reliability of the aggregated estimates.

When considered collectively, the statistical outputs provide a coherent and internally consistent narrative. The pooled effect sizes demonstrate clear and reproducible trends, while heterogeneity analyses offer valuable insight into the contextual factors shaping study-level outcomes. The consistency observed across sensitivity analyses and the limited evidence of publication bias further enhance confidence in the findings.

Rather than presenting a simplistic aggregation of data, the statistical analysis captures the nuanced reality of a complex evidence base. The combination of quantitative rigor and transparent visualization allows for a balanced interpretation that acknowledges variability without obscuring overarching patterns. This integrative approach ensures that the results are both statistically sound and scientifically meaningful.

In summary, the statistical analysis reveals robust pooled effects supported by multiple independent studies, tempered by understandable heterogeneity and methodological diversity. The results presented here establish a strong quantitative foundation for subsequent discussion and underscore the value of systematic synthesis in advancing evidence-based understanding within this research domain.

4. Discussion

The present systematic synthesis highlights the persistent and multifaceted challenges associated with activating, regulating, and exploiting secondary metabolism in Streptomyces and related actinomycetes, while simultaneously underscoring the remarkable plasticity of these organisms as natural product factories. The integrated findings reinforce the idea that secondary metabolite production is not an isolated biosynthetic event but a tightly regulated outcome of developmental programs, cellular differentiation, and environmental signaling. A comparison of enhancement-oriented versus cryptic pathway activation strategies is presented in Table 2. This perspective aligns strongly with earlier conceptual frameworks proposing a “new science of secondary metabolism,” where metabolite biosynthesis is inseparable from global regulatory networks and physiological state (Craney et al., 2013).

A central theme emerging from the discussion is the developmental coupling between morphological differentiation and antibiotic production. Classic and contemporary studies consistently demonstrate that growth polarity, mycelial differentiation, and programmed cell death are integral to metabolic switching in Streptomyces (Flärdh, 2003; Manteca et al., 2005; Manteca et al., 2008). These processes create spatial and temporal subpopulations within the mycelium, enabling localized activation of biosynthetic gene clusters. Subcompartmentalization of the mycelium further refines this process, allowing specialized zones of metabolic activity that favor secondary metabolite accumulation (Yagüe et al., 2016). The current synthesis supports the notion that overlooking these developmental dimensions can lead to underestimation of biosynthetic potential in conventional screening approaches.

Morphology at the macroscopic level, particularly pellet formation in liquid cultures, also plays a decisive role in metabolite yield and reproducibility. Pellet structure influences oxygen diffusion, nutrient gradients, and local stress conditions, all of which modulate secondary metabolism (Park et al., 1997; Sarra et al., 1997). Empirical models linking morphology to production, such as those developed for retamycin and nystatin, demonstrate that productivity is often maximized within narrow morphological windows rather than through simple biomass accumulation (Giudici et al., 2004; Jonsbu et al., 2002). These observations reinforce the idea that fermentation optimization must integrate morphological control strategies to fully harness biosynthetic capacity.

Beyond development and morphology, genetic and regulatory interventions have proven powerful in awakening cryptic or silent biosynthetic gene clusters. Ribosomal mutations and stress-induced regulatory perturbations have repeatedly been shown to unlock otherwise inaccessible chemical diversity (Hosaka et al., 2009; Yoon & Nodwell, 2014). Similarly, targeted mutagenesis and transposition-based approaches reveal that relatively small genetic disruptions can trigger large metabolic shifts, often by relieving repression or activating global regulators (Khaliq et al., 2009; Xu et al., 2017). The effectiveness of such strategies underscores the inherent readiness of actinomycete genomes to respond to perturbation, supporting the view that silence of gene clusters is often conditional rather than absolute.

Chemical and biological signaling further complicates the regulatory landscape. Small molecules, including endogenous antibiotics themselves, can act as signaling compounds that feedback into regulatory circuits, coordinating population-level responses (Wang et al., 2014). Co-cultivation experiments expand this concept by demonstrating that interspecies interactions can dramatically reshape metabolite profiles, often leading to the production of compounds not observed in monoculture (Marmann et al., 2014). These findings resonate with ecological perspectives on secondary metabolism, particularly in symbiotic or competitive environments where chemical communication is essential (Piel, 2004).

Advances in transcriptomics and proteomics have provided deeper insight into the regulatory hierarchies governing secondary metabolism. Global expression analyses reveal that activation of biosynthetic pathways is often accompanied by widespread reprogramming of cellular metabolism, stress responses, and developmental genes (Yagüe et al., 2014; Manteca et al., 2010). Such systems-level shifts challenge reductionist approaches that focus on single genes or clusters in isolation. Instead, they argue for integrated strategies that consider regulatory cascades, post-translational modifications, and metabolic flux redistribution (Worrall & Vijgenboom, 2010).

From a biosynthetic perspective, post-polyketide synthase tailoring steps play a crucial role in generating structural diversity and bioactivity. Enzymatic modifications such as glycosylation, oxidation, and methylation significantly expand chemical space beyond core scaffolds (Olano et al., 2010). Case studies of complex pathways, including paulomycin biosynthesis, illustrate how subtle regulatory or enzymatic changes can yield distinct metabolite profiles with altered biological properties (González et al., 2016). These observations reinforce the importance of pathway-level understanding for rational manipulation and drug discovery.

The broader significance of these findings lies in the continued relevance of actinomycetes as sources of novel antibiotics and bioactive compounds. Despite decades of exploration, these organisms remain prolific producers of structurally and functionally diverse metabolites (Genilloud, 2014; Genilloud, 2017). Heterologous expression systems and synthetic biology approaches offer additional avenues for accessing this diversity, particularly when native regulatory constraints limit expression (Baltz, 2010; Baltz, 2017). Synthetic activators and engineered regulatory circuits exemplify how rational design can complement traditional discovery methods (Ahmed et al., 2013; Daniel-Ivad et al., 2017).

Importantly, the discussion also highlights the need to bridge laboratory-scale insights with industrial applicability. Studies examining differentiation and productivity in bioreactors demonstrate that developmental regulation persists under large-scale conditions, albeit in modified forms (Rioseras et al., 2014). Understanding how physical parameters, shear forces, and nutrient delivery interact with regulatory networks remains critical for translating biosynthetic potential into reliable production processes (Vecht-Lifshitz et al., 1992).

In summary, the collective evidence reinforces a paradigm in which secondary metabolism in Streptomyces is an emergent property of development, regulation, and ecological interaction rather than a simple output of isolated gene clusters. By integrating insights from genetics, physiology, ecology, and engineering, this synthesis underscores why actinomycetes continue to be indispensable to natural product research. Future progress will depend on embracing this complexity, leveraging systems-level tools, and strategically perturbing regulatory networks to unlock the full chemical potential encoded within these remarkable microbial genomes (Onaka, 2017).

5. Limitations

Despite the comprehensive scope and rigorous methodology of this systematic review and meta-analysis, several limitations should be acknowledged. First, the analysis was constrained by the heterogeneity of the included studies, particularly with respect to experimental design, cultivation conditions, regulatory strategies, and outcome measures. Although random-effects models were applied to account for variability, residual heterogeneity may still influence the precision of pooled estimates. Second, the reliance on published literature introduces an inherent risk of publication bias, as studies reporting negative or inconclusive findings are less likely to be published, even though funnel plot analysis suggested minimal asymmetry. Third, many included studies were conducted under laboratory-scale conditions, which may limit the direct extrapolation of findings to industrial or environmental settings. Fourth, incomplete reporting of methodological details in some studies restricted deeper subgroup or meta-regression analyses, particularly regarding regulatory mechanisms and morphological parameters. Finally, language and database restrictions may have resulted in the exclusion of relevant non-English or regionally published studies, potentially narrowing the global representativeness of the evidence base.

6. Conclusion

This study demonstrates that secondary metabolism in Streptomyces is a developmentally regulated, highly plastic process shaped by genetic, physiological, and environmental interactions. Systematic synthesis confirms robust trends across diverse studies while highlighting heterogeneity as an intrinsic feature of biosynthetic regulation. These findings reinforce the value of integrated, systems-level strategies for unlocking cryptic metabolic potential and advancing natural product discovery.

References